Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Intervent International, Savannah, Georgia.
J Am Coll Cardiol. 2015 Feb 3;65(4):389-395. doi: 10.1016/j.jacc.2014.10.059.
Atherosclerotic cardiovascular disease (ASCVD) continues to increase annually in the United States along with its associated enormous costs. A multidisciplinary cardiac rehabilitation (CR) and risk reduction program is an essential component of ASCVD prevention and management. Despite the strong evidence for CR in the secondary prevention of ASCVD, it remains vastly underutilized due to significant barriers. The current model of CR delivery is unsustainable and needs significant improvement to provide cost-effective, patient-centered, comprehensive secondary ASCVD prevention.
在美国,动脉粥样硬化性心血管疾病(ASCVD)的发病率逐年上升,其相关的巨大费用也随之增加。多学科心脏康复(CR)和风险降低计划是 ASCVD 预防和管理的重要组成部分。尽管有强有力的证据表明 CR 可用于 ASCVD 的二级预防,但由于存在重大障碍,其使用率仍然极低。目前的 CR 提供模式是不可持续的,需要进行重大改进,以提供具有成本效益、以患者为中心、全面的二级 ASCVD 预防。